# Citius Pharmaceuticals, Inc. — Form D

Citius Pharmaceuticals, Inc. of CRANFORD, NJ, a company, filed a Form D exempt-offering notice with the SEC on 2021-02-01. The offering totals $20.0M, of which $20.0M was reported sold. Industry: Pharmaceuticals.

## Offering

- Filed: 2021-02-01
- Form: D
- Accession: 0001213900-21-005652
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $20.0M
- Amount sold: $20.0M
- Investors: 7
- Date of first sale: 2021-01-27
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-387992

## Issuer

- Name: Citius Pharmaceuticals, Inc.
- CIK: 0001506251
- Entity type: Corporation
- Jurisdiction: NEVADA
- Incorporated: 2010
- Address: 11 COMMERCE DRIVE 1ST FLOOR, CRANFORD, NJ, 07016
- Phone: (908) 967-6676

## Officers, directors & promoters (20)

| Name | Role | Location |
| --- | --- | --- |
| Suren Dutia | Director | Cranford, NJ |
| Myron Holubiak | Director | Cranford, NJ |
| Eugene Holuka | Director | Cranford, NJ |
| William Kane | Director | Cranford, NJ |
| Leonard Mazur | Director | Cranford, NJ |
| Howard Safir | Director | Cranford, NJ |
| Carol Webb | Director | Cranford, NJ |
| Jaime Bartushak | Executive Officer | Cranford, NJ |
| Myron Holubiak | Executive Officer | Cranford, NJ |
| Leonard Mazur | Executive Officer | Cranford, NJ |
| Leonard Mazur | Related Person | Cranford, NJ |
| Suren Dutia | Related Person | Cranford, NJ |
| Howard Safir | Related Person | Cranford, NJ |
| Carol Webb | Related Person | Cranford, NJ |
| Myron Holubiak | Related Person | Cranford, NJ |
| Eugene Holuka | Related Person | Cranford, NJ |
| Jaime Bartushak | Related Person | Cranford, NJ |
| William Kane | Related Person | Cranford, NJ |
| Ralph Montrone | Director | Salt Lake City, UT |
| Ralph Montrone | Executive Officer | Salt Lake City, UT |

## Other filings by this issuer (7)

| Filed | Form | Offering | Sold |
| --- | --- | --- | --- |
| [2020-05-19](https://search.stillhousedata.com/formd/0001213900-20-012897) | D | $3.5M | $221K |
| [2019-04-08](https://search.stillhousedata.com/formd/0001213900-19-005961) | D | $429K | $429K |
| [2018-05-22](https://search.stillhousedata.com/formd/0001213900-18-006720) | D | $84K | $84K |
| [2017-12-20](https://search.stillhousedata.com/formd/0001213900-17-013459) | D | $40K | $40K |
| [2017-02-27](https://search.stillhousedata.com/formd/0001578563-17-000005) | D/A | $6.0M | $550K |
| [2016-12-08](https://search.stillhousedata.com/formd/0001578563-16-000023) | D | $6.0M | $390K |
| [2011-10-26](https://search.stillhousedata.com/formd/0001019687-11-003268) | D | $8K | $8K |

## More

- [CIK 1506251 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1506251&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001213900-21-005652.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.